Fantastic results its statistically signifcant. Now onto the Orphan Drug Designation.
Phase 3 in 2025 wat mentioned by MT thats amazing !
- Forums
- ASX - By Stock
- Ann: Positive Phase 1 MEND Study Top-Line Results
Fantastic results its statistically signifcant. Now onto the...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $95.88M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.3¢ | $33.14K | 167.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14455 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6557 | 0.195 |
9 | 309878 | 0.190 |
11 | 720520 | 0.185 |
7 | 380800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 27861 | 2 |
0.205 | 101604 | 4 |
0.210 | 148876 | 3 |
0.215 | 154400 | 2 |
0.220 | 190000 | 3 |
Last trade - 12.00pm 18/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online